Related Experiment Videos
High-affinity CD25-binding IL-2 mutants potently stimulate persistent T cell growth
Balaji M Rao1, Ian Driver, Douglas A Lauffenburger
1Department of Chemical Engineering, Massachusetts Institute of Technology, Building 66-552, 77 Massachusetts Avenue, Cambridge, Massachusetts 01239, USA.
Biochemistry
|August 3, 2005
Summary
Researchers engineered interleukin-2 (IL-2) mutants with high affinity for the IL-2 alpha receptor (IL-2Ralpha). These IL-2 mutants promote prolonged T cell proliferation, suggesting potential in cancer and viral immunotherapies.
Area of Science:
- Immunology
- Molecular Biology
- Biotechnology
Background:
- Interleukin-2 (IL-2) and Interleukin-15 (IL-15) have distinct effects on T cell proliferation and survival.
- The differing affinities of IL-2 and IL-15 for their respective alpha receptor subunits (IL-2Ralpha/CD25 and IL-15Ralpha) are hypothesized to contribute to these contrasting effects.
- Understanding these receptor-ligand interactions is crucial for developing targeted immunotherapies.
Purpose of the Study:
- To engineer IL-2 mutants with enhanced binding affinity to the IL-2 alpha receptor (IL-2Ralpha/CD25).
- To investigate the impact of these engineered IL-2 mutants on T cell proliferation and compare their activity to IL-15.
- To elucidate the role of alpha receptor binding affinity in mediating the differential effects of IL-2 and IL-15 on T cells.
Main Methods:
- Directed evolution was employed to generate IL-2 mutants with improved binding to IL-2Ralpha.
- Binding affinities of IL-2 mutants were compared to the IL-15/IL-15Ralpha interaction.
- T cell proliferation assays were conducted following short incubation periods with IL-2 mutants.
- T cell growth response-receptor occupancy curves were analyzed and compared to IL-15.
Main Results:
- IL-2 mutants were successfully constructed exhibiting binding affinities for IL-2Ralpha comparable to the IL-15/IL-15Ralpha interaction.
- Incubation with these IL-2 mutants led to sustained T cell proliferation for up to 6 days.
- The T cell growth response-receptor occupancy curves for the IL-2 mutants were indistinguishable from those of IL-15.
- These findings suggest that the 1000-fold difference in alpha receptor affinity between wild-type IL-2 and IL-15 significantly contributes to their distinct biological outcomes.
Conclusions:
- Engineered IL-2 mutants can achieve high-affinity binding to IL-2Ralpha, mimicking aspects of the IL-15 signaling pathway.
- Sustained T cell proliferation induced by these IL-2 mutants holds promise for applications in cancer and viral immunotherapy.
- The affinity for the private alpha receptor subunit plays a critical role in determining the magnitude and duration of T cell responses to IL-2 and IL-15.